Supplier
Cardiovascular Consultants LTD
Cardiovascular Consultants LTD was paid $7.04M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoCARDIOVASCULAR CONSULTANTS LTD
PHOENIX, AZ 85032
PHOENIX, AZ 85032
33aNPI1023073525assigned 04/18/2006
33bProvider typeNon-Pharmacy Dispensing Site
28Total paid$7.04M
24GClaims158,562
24DCodes billed52
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Non-Pharmacy Dispensing Site providers in Arizona
Rank by total paid#1 of 6
Median peer was paid$448K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,514 | $1.23M | |
| 2019 | 28,282 | $1.15M | |
| 2020 | 28,106 | $1.35M | |
| 2021 | 22,495 | $1.08M | |
| 2022 | 19,185 | $871K | |
| 2023 | 16,232 | $773K | |
| 2024incomplete | 13,748 | $584K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 38,662 | 35,532 | $1.90M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 22% | 17,260 | 16,681 | $1.55M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 9.0% | 11,547 | 3,954 | $637K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.0% | 18,987 | 17,862 | $634K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.0% | 4,212 | 4,030 | $350K |
| 93000 | 4.6% | 34,490 | 33,247 | $325K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 3.8% | 1,291 | 1,160 | $265K |
| 99223 | Prolong inpt eval add15 m | 3.2% | 2,312 | 2,194 | $226K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.6% | 5,396 | 2,578 | $183K |
| J2785 | Injection, regadenoson, 0.1 mg | 2.1% | 1,338 | 1,212 | $151K |
| 93015 | 1.9% | 3,302 | 2,985 | $131K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1.7% | 1,213 | 1,044 | $122K |
40 more codes
| 78492 | <1% | 142 | $68K | |
| 97803 | <1% | 729 | $44K | |
| 93880 | <1% | 497 | $44K | |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | <1% | 135 | $42K |
| 93925 | <1% | 271 | $36K | |
| 97802 | <1% | 313 | $33K | |
| 93295 | <1% | 1,493 | $32K | |
| 93298 | <1% | 2,056 | $31K | |
| 93297 | <1% | 2,472 | $28K | |
| 93970 | <1% | 225 | $26K | |
| 93294 | <1% | 1,809 | $22K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 131 | $19K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 266 | $18K |
| 93296 | <1% | 1,700 | $18K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 285 | $15K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,554 | $14K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 278 | $12K |
| 93458 | <1% | 59 | $11K | |
| 93793 | <1% | 1,600 | $10K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 125 | $9K |
| 75574 | <1% | 53 | $8K | |
| 93285 | <1% | 237 | $7K | |
| 93280 | <1% | 277 | $6K | |
| 85610 | <1% | 1,374 | $2K | |
| 93225 | <1% | 125 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 87 | $2K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 13 | $2K |
| 93978 | <1% | 15 | $1K | |
| 93923 | <1% | 14 | $963.16 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 35 | $906.89 |
| 93224 | <1% | 13 | $827.19 | |
| 93227 | <1% | 40 | $775.66 | |
| 99225 | <1% | 19 | $594.95 | |
| 75571 | <1% | 13 | $479.66 | |
| 93284 | <1% | 15 | $405.66 | |
| 94618 | <1% | 12 | $251.49 | |
| 93242 | <1% | 16 | $190.00 | |
| 93228 | <1% | 13 | $189.30 | |
| 99152 | <1% | 29 | $171.38 | |
| 93299 | <1% | 12 | $106.97 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHADEN, CHRISTY (CEO)